← Back to Clinical Trials
Recruiting NCT06391073

NCT06391073 Reach Out 2: Emergency Department-Initiated Hypertension Mobile Health Intervention Connecting Multiple Health Systems

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06391073
Status Recruiting
Phase
Sponsor Northwestern University
Condition Hypertension
Study Type INTERVENTIONAL
Enrollment 500 participants
Start Date 2024-07-22
Primary Completion 2028-03-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 99 Years
Study Type INTERVENTIONAL
Interventions
Self-Measured Blood Pressure MonitoringPhysician appointment and transportation scheduling

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 500 participants in total. It began in 2024-07-22 with a primary completion date of 2028-03-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Emergency department visits provide an opportunity to identify people with undiagnosed, untreated, or uncontrolled high blood pressure. In Reach Out, we will test whether a mobile health intervention yields a greater reduction in blood pressure than usual care among individuals identified with high blood pressure during a safety-net emergency department visit. Subsequently, we will estimate the reduction in heart attack, stroke, and dementia if Reach Out were implemented across all U.S. safety-net emergency departments.

Eligibility Criteria

While in the ED, the patient must meet all of the following: * Adult (≥18 y/o) * At least one BP with Systolic BP ≥160 or a Diastolic BP ≥100 (criteria 1) * If the patient has repeated measurements after achieving Criteria 1, at least one of the repeat BP remains systolic BP ≥140 or a diastolic BP ≥90 * Must have cell phones with text-messaging capability * Likely to be discharged from the ED Exclusion Criteria for Main Trial Participants: * Critical illness * Unable to read English (\<1% at study site) * Incarcerated * Pregnant * Pre-existing condition making 6-month follow-up unlikely

Contact & Investigator

Central Contact

Lesli Skolarus, MD, MS

✉ lesli.skolarus@northwestern.edu

📞 312-503-0644

Frequently Asked Questions

Who can join the NCT06391073 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06391073 currently recruiting?

Yes, NCT06391073 is actively recruiting participants. Contact the research team at lesli.skolarus@northwestern.edu for enrollment information.

Where is the NCT06391073 trial being conducted?

This trial is being conducted at Flint, United States.

Who is sponsoring the NCT06391073 clinical trial?

NCT06391073 is sponsored by Northwestern University. The trial plans to enroll 500 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology